Paige stock

Paige Stock

HealthTech

Looking to sell Paige stock or options?

Founded: 2017Funding to Date: $247Mhttps://www.paige.ai

Paige is the developer of a computational pathology module platform designed for swift diagnostic categorization and cancer detection. This platform utilizes a deep learning algorithm built on convolutional and recurrent neural networks, as well as generative models, with a focus on breast, prostate, and other major cancer types. It enables clinical researchers and pathologists to grasp the progression of diseases with various mutations, facilitating more efficient treatment.

Investors Include:

Casdin Capital, Kenan Turnacioglu, HealthCare Ventures, AI Venture Labs, Kohlberg Kravis Roberts, Healthcare Venture Partners, Catalio Capital Management, Memorial Sloan Kettering Cancer Center, Palkon Capital Management, Breyer Capital, Goldman Sachs Asset Management, Johnson & Johnson Innovation - JJDC.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more